| ST1467-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 1.0 mg | erbB-2 | 1.0 mg | $152.25 | |
| ST1468-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 1.0 mg | erbB-2 | 1.0 mg | $787.50 | |
| ST1463-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 100 mg | erbB-2 | 100 mg | $5,197.50 | |
| ST1465-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 25 mg | erbB-2 | 25 mg | $2,073.75 | |
| ST1464-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 5.0 mg | erbB-2 | 5.0 mg | $577.50 | |
| ST1466-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 50 mg | erbB-2 | 50 mg | $3,937.50 | |
| ST1469-4 |
Anti-erbB-2 (Her-2/neu) (Margetuximab) - 500 µg | erbB-2 | 500 µg | $417.90 | |
| ST1490-4 |
Anti-Human BCMA (Belantamab) - 1.0 mg | BCMA | 1.0 mg | $152.25 | |
| ST1491-4 |
Anti-Human BCMA (Belantamab) - 100 mg | BCMA | 100 mg | $5,197.50 | |
| ST1492-4 |
Anti-Human BCMA (Belantamab) - 25 mg | BCMA | 25 mg | $2,073.75 | |
| ST1493-4 |
Anti-Human BCMA (Belantamab) - 5.0 mg | BCMA | 5.0 mg | $577.50 | |
| ST1494-4 |
Anti-Human BCMA (Belantamab) - 50 mg | BCMA | 50 mg | $3,937.50 | |
| ST1495-4 |
Anti-Human BCMA (Belantamab) - 500 µg | BCMA | 500 µg | $417.90 | |
| ST1430-4 |
Anti-Human CD11a (Efalizumab) - 1.0 mg | CD11a | 1.0 mg | $183.75 | |
| ST1450-4 |
Anti-Human CD11a (Efalizumab) - 100 mg | CD11a | 100 mg | $5,355.00 | |
| ST1431-4 |
Anti-Human CD11a (Efalizumab) - 25 mg | CD11a | 25 mg | $2,572.50 | |
| ST1432-4 |
Anti-Human CD11a (Efalizumab) - 5.0 mg | CD11a | 5.0 mg | $682.50 | |
| ST1449-4 |
Anti-Human CD11a (Efalizumab) - 50 mg | CD11a | 50 mg | $3,937.50 | |
| ST1451-4 |
Anti-Human CD11a (Efalizumab) - 500 µg | CD11a | 500 µg | $393.75 | |
| ST1433-4 |
Anti-Human CD194 (CCR4) (Mogamulizumab) - 1.0 mg | CD194 | 1.0 mg | $152.25 | |
| ST1440-4 |
Anti-Human CD194 (CCR4) (Mogamulizumab) - 100 mg | CD194 | 100 mg | $5,197.50 | |
| ST1434-4 |
Anti-Human CD194 (CCR4) (Mogamulizumab) - 25 mg | CD194 | 25 mg | $2,073.75 | |
| ST1435-4 |
Anti-Human CD194 (CCR4) (Mogamulizumab) - 5.0 mg | CD194 | 5.0 mg | $577.50 | |
| ST1439-4 |
Anti-Human CD194 (CCR4) (Mogamulizumab) - 50 mg | CD194 | 50 mg | $3,937.50 | |
